Paclitaxel and carboplatin adjuvant therapy alone or with radiotherapy for resected nonsmall cell lung carcinoma: a feasibility study of the Minnie Pearl Cancer Research Network.

@article{Greco2001PaclitaxelAC,
  title={Paclitaxel and carboplatin adjuvant therapy alone or with radiotherapy for resected nonsmall cell lung carcinoma: a feasibility study of the Minnie Pearl Cancer Research Network.},
  author={Frank Anthony Greco and Howard A. Burris and James Richard Andrew Gray and Eric L. Raefsky and Caleb W. Dobbs and Stephanie W Smith and David A. Rinaldi and Lisa H Morrissey and Joan B Erland and Sharlene Litchy and John D Hainsworth},
  journal={Cancer},
  year={2001},
  volume={92 8},
  pages={2142-7}
}
BACKGROUND The objective of this study was to determine the feasibility and toxicity of paclitaxel and carboplatin given in the adjuvant setting alone for patients with resected Stage IB disease and combined with radiotherapy for patients with resected Stages II and IIIA disease and selected patients with Stage IIIB and IV disease (Revised International System for Staging of Lung Cancer). METHODS One hundred two patients with resected nonsmall cell lung carcinoma were treated in the… CONTINUE READING